Skip to main content
. 2017 Aug 5;8(40):67117–67128. doi: 10.18632/oncotarget.19962

Figure 2. Markers of proliferation and inflammation predict poor clinical outcome in gastric cancer patients.

Figure 2

We assessed the predictive value of Ki67 and PCNA in N = 359 gastric cancer patients. A. Note that high transcript levels of Ki67 and PCNA are associated with significantly reduced time to first progression. Note that the official gene name for the Ki67 protein is MKI67. B. Note that that high transcript levels of CD163 are associated with significantly reduced time to first progression.